1. Clinical Overview
Ropinirole is a non-ergoline dopamine agonist used primarily for the treatment of Parkinson's disease and Restless Legs Syndrome (RLS). It selectively stimulates dopamine D2-type receptors within the caudate-putamen in the brain, compensating for the deficiency of dopamine, a key neurotransmitter. The 0.5mg strength is typically used for initial dose titration and for the management of moderate to severe primary RLS.
| Onset | Duration | Bioavailability |
|---|---|---|
| Approximately 1 to 2 hours for RLS symptom relief; may take weeks for full effect in Parkinson's disease. | Approximately 6 to 8 hours (immediate-release formulation). | Approximately 55% (absolute bioavailability). |
2. Mechanism of Action
Ropinirole is a selective agonist for dopamine D2 and D3 receptor subtypes, with higher affinity for D3. In Parkinson's disease, it directly stimulates postsynaptic dopamine receptors in the striatum, compensating for the depleted dopamine in the nigrostriatal pathway. In Restless Legs Syndrome, its mechanism is believed to involve modulation of dopaminergic neurotransmission in the spinal cord and possibly the A11 diencephalic dopaminergic neurons, which project to the spinal cord.
3. Indications & Uses
- Idiopathic Parkinson's Disease (as monotherapy in early disease or as adjunct to levodopa in advanced disease)
- Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
4. Dosage & Administration
Adult Dosage: Parkinson's: Start 0.25 mg TID. Titrate weekly by 0.25 mg TID to effective dose (typically 3-9 mg/day in 3 divided doses). Max: 24 mg/day. RLS: Start 0.25 mg once daily, 1-3 hours before bedtime. May increase after 2 days to 0.5 mg, then to 1 mg, 1.5 mg, 2 mg, and 3 mg as needed, with at least 2 days between increments. Max for RLS: 4 mg/day.
Administration: Take with food to reduce nausea. For RLS, take 1 to 3 hours before bedtime. Tablets should be swallowed whole with water. Do not crush or chew. Maintain a consistent schedule. If a dose is missed, skip it and take the next dose at the regular time. Do not double dose.
5. Side Effects
Common side effects may include:
- Nausea
- Dizziness
- Somnolence (drowsiness)
- Headache
- Vomiting
- Fatigue
- Syncope (fainting), especially during initial titration
- Orthostatic hypotension
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Ciprofloxacin, Fluvoxamine | Inhibits CYP1A2, increasing ropinirole plasma levels and risk of toxicity. | Major |
| Omeprazole, Smoking | Induces CYP1A2, decreasing ropinirole plasma levels and potential efficacy. | Moderate |
| Levodopa/Carbidopa | Enhances dopaminergic effects; may allow reduction of levodopa dose but also increases risk of dyskinesias, hallucinations, and orthostasis. | Moderate |
| Antipsychotics (e.g., Haloperidol, Chlorpromazine, Risperidone) | Antagonize dopamine receptors, reducing efficacy of ropinirole. Can worsen Parkinsonism. | Major |
| Metoclopramide, Domperidone | Domperidone (peripheral antagonist) is safer. Metoclopramide crosses BBB and can antagonize central effects. | Moderate |
| Antihypertensives | Additive hypotensive effect, increasing risk of dizziness and syncope. | Moderate |
| CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Additive sedative effects, increasing risk of somnolence and sudden sleep onset. | Major |
| Estrogens (e.g., Hormone Replacement Therapy) | May inhibit metabolism of ropinirole, increasing its concentration. Dose adjustment may be needed. | Moderate |
7. Patient Counselling
- DO take the medication exactly as prescribed, at the same times each day.
- DO take with food if nausea occurs.
- DO rise slowly from sitting or lying position to avoid dizziness.
- DO inform all your doctors and surgeons you are taking this medicine.
- DO regularly examine your skin for new moles or changes in existing ones.
- DONT stop taking the medicine suddenly. Always consult your doctor for a tapering schedule.
- DONT drive, operate heavy machinery, or engage in hazardous activities until you know how the medicine affects you.
- DONT drink alcohol while on this medication.
- DONT take any other prescription, OTC, or herbal medicine without consulting your doctor or pharmacist.
8. Toxicology & Storage
Overdose: Expected dopaminergic overstimulation: Nausea, vomiting, dizziness, visual hallucinations, hyperhidrosis, agitation, hypotension, tachycardia, cardiac arrhythmias, and severe sedation. Overdoses >100 mg have been reported with full recovery.
Storage: Store below 30°C. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.